4-(4-BENZOYL-2-PHENYL-5,6-DIHYDRO-4H-1,3,4-OXADIAZIN-6-YL)PHENYL METHYL ETHER
UNII QG943TJF8L

Substance Identification & Data

This profile provides standardized clinical and technical data for 4-(4-benzoyl-2-phenyl-5,6-dihydro-4h-1,3,4-oxadiazin-6-yl)phenyl Methyl Ether, uniquely identified by the FDA Unique Ingredient Identifier (UNII) QG943TJF8L.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 73239-82-4 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

QG943TJF8L

CAS Registry Number

73239-82-4

RxNorm Concept ID

N/A

Detailed Substance Profile

Preferred Name

4-(4-BENZOYL-2-PHENYL-5,6-DIHYDRO-4H-1,3,4-OXADIAZIN-6-YL)PHENYL METHYL ETHER

Official standardized name for this substance within the FDA UNII nomenclature system.

InChIKey

C23H20N2O3

International Chemical Identifier digital signature for unique molecular identification.

SMILES String

RHXNRQRNNFGWSU-UHFFFAOYSA-N

Line notation for describing the chemical structure and connectivity of atoms.

PubChem CID

338392

Unique identification number in the NCBI database of chemical substances.

Substance Type

chemical

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Ingredient Role

COc1ccc(cc1)C2CN(C(=O)c3ccccc3)N=C(c4ccccc4)O2

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for 4-(4-benzoyl-2-phenyl-5,6-dihydro-4h-1,3,4-oxadiazin-6-yl)phenyl Methyl Ether. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.